Related Experiment Video
Updated: May 13, 2026

15:22
Nucleoside Triphosphates - From Synthesis to Biochemical Characterization
Published on: April 3, 2014
Methylenediphosphonotetrathioate: synthesis, characterization, and chemical properties
Aviran Amir1, Alon Haim Sayer, Alon Ezra
1Department of Chemistry, Bar Ilan University, Ramat-Gan 52900, Israel.
Inorganic Chemistry
|March 5, 2013
Summary
A novel metal chelator, methylenediphosphonotetrathioate (MDPT), shows high selectivity for toxic metal ions like Zn(II) and Cu(I) over Ca(II). Its stability in acidic and basic conditions offers therapeutic potential for metal-related diseases.
Area of Science:
- Medicinal Chemistry
- Inorganic Chemistry
- Biochemistry
Background:
- Metal dyshomeostasis, involving excess copper (Cu(II)) and zinc/copper/iron (Zn(II)/Cu(II)/Fe(II/III)), is implicated in neurodegenerative diseases like Wilson's and Alzheimer's.
- Effective therapeutic strategies require metal chelators with high affinity and selectivity for target metal ions, especially in complex physiological environments rich in other metal ions.
Purpose of the Study:
- To synthesize and characterize a novel tetrathioate chelator, methylenediphosphonotetrathioate (MDPT), as a potential therapeutic agent.
- To evaluate the metal-binding properties and selectivity of MDPT, particularly its affinity for Zn(II) and inhibitory activity against metal-catalyzed oxidative stress.
Main Methods:
- Synthesis of MDPT via a 3-step process from bis-methylene(phosphonicdichloride).
- Determination of metal complex stability using equilibrium constants (log K) and comparison with existing chelators like MDP and EDTA.
- Assessment of inhibitory activity against Cu(I)-catalyzed Fenton reactions using electron spin resonance (ESR).
- Evaluation of MDPT stability in acidic and basic media using NMR spectroscopy.
Main Results:
- MDPT demonstrated a high affinity for Zn(II) (log K = 10.84), forming a complex 10^7 times more stable than its Ca(II) complex.
- The MDPT-Zn(II) complex was 50-fold more stable than the corresponding methylenediphosphonic acid (MDP)-Zn(II) complex.
- MDPT potently inhibited Cu(I)-catalyzed Fenton reactions (IC50 = 26 μM), outperforming EDTA (IC50 = 64 μM).
- MDPT exhibited good stability in acidic (pD 1.9) and basic (pD 12.4) conditions, with half-lives of 71.5 and 81 hours, respectively.
Conclusions:
- MDPT is a water-soluble chelator with a strong preference for soft/borderline metal ions and remarkable selectivity against Ca(II).
- Its potent inhibition of metal-catalyzed oxidative reactions suggests therapeutic potential for diseases involving such mechanisms.
- While MDPT's sensitivity to oxidation in neutral air may limit its application, its enhanced stability in acidic or basic media broadens its potential therapeutic utility.

